TLC domain-containing protein 2 (TLCD2)

TLC domain-containing protein 2 (TLCD2) is a plasma membrane protein involved in the regulation of membrane assembly, phospholipid homeostasis, and membrane lipid distribution[1][6]. It plays a significant role in controlling the composition and fluidity of the plasma membrane, notably inhibiting the incorporation of membrane-fluidizing phospholipids that contain omega-3 long-chain polyunsaturated fatty acids, thereby promoting membrane rigidity[1]. TLCD2 is a member of the TLC (Tram-Lag-CLN8) domain-containing protein family, which includes several subclasses such as ceramide synthases, TRAM proteins, and acyltransferases, but the brief available evidence does not categorize TLCD2 into a well-known therapeutic target family like receptor, enzyme, transporter, or channel[2]. There are currently no known drugs that interact directly with TLCD2, nor are there established mechanisms of action, biomarker applications, or reported safety concerns associated with this protein. Its direct clinical and pharmacological relevance remains poorly characterized[1][2][6].

Other names

TLC domain-containing protein 2TLCD2